Your Health Questions
Answered by Professionals

Clinical trials for depression are generally safe under strict medical and ethical oversight with informed consent, careful screening, and close monitoring, but they are not risk-free and can involve side effects, placebo assignment, or temporary symptom worsening. There are several factors to consider when deciding your next steps, including your symptom severity, eligibility, and whether standard care is provided, so see the complete guidance below on who may benefit, who should be cautious, and the key questions to ask your doctor.

There are several factors to consider with biologic failure in IBD: a drug may never work or stop working due to antibodies, low levels, shifting inflammation pathways, non-IBD causes, or structural damage, leading to persistent symptoms and abnormal inflammatory markers. Next steps usually include therapeutic drug monitoring, dose optimization, switching drug classes, possible combination therapy, or surgery, plus checking for infections or IBS mimics and knowing when urgent care is needed. See the complete guidance below, since key details and risks can change which path is right for you.

There are several factors to consider; see below to understand more. Biologic therapies can fail due to primary non-response, antibody-related loss of response, low drug levels, or misdiagnosis, so re-evaluation with infection checks and drug-level testing is the first step. Next options include switching to a different class, using small molecule oral therapies, optimizing or combining treatments, exploring clinical trials, or considering curative surgery; see below for key risks, monitoring targets like mucosal healing, and urgent symptoms that could change the best next step.

A Bipolar 1 manic episode is a medical brain state marked by dysregulated dopamine and other neurotransmitters, disrupted sleep-wake rhythms, and impaired impulse control that can quickly impact judgment, safety, and long-term stability. New, evidence-based steps like mood stabilizers such as lithium, atypical antipsychotics, urgent sleep stabilization, structured therapy, and close monitoring can restore balance and prevent relapse; there are several factors to consider, so see the complete guidance below for key details that could shape your next healthcare steps.

Bipolar insomnia happens when mood instability keeps the brain wired through circadian rhythm disruption and dopamine shifts, leading to a reduced need for sleep that can trigger or signal mania, hypomania, or depression. Effective medical steps include mood stabilizers and sedating atypical antipsychotics, carefully used short-term sleep aids, IPSRT, CBT-I tailored for bipolar disorder, cautious light therapy, and strict daily rhythm habits, with urgent care needed if sleep disappears for 24 to 48 hours or risky behavior emerges. There are several factors to consider; see below for the full guidance and key details that can shape your next healthcare steps.

If your bipolar medications are not working, precision medicine offers a targeted path that personalizes care to your biology, symptom patterns, and risks rather than trial and error. Discuss next steps like reconfirming the diagnosis, checking therapeutic drug levels, considering pharmacogenomic testing, evaluating thyroid, inflammation, and sleep and circadian factors, treating co-occurring conditions, and when needed using evidence-based options such as ECT, TMS, ketamine, or clozapine alongside structured lifestyle strategies. There are several factors to consider. See below for a step-by-step checklist, urgent red flags, and how to prepare for your next appointment.

Stem cell therapy is not an approved or proven treatment for bipolar disorder; current stem cell science is mainly a research tool that may guide future personalized medications but is not a clinical option today. If your meds are failing, evidence-based next steps include a diagnostic review, optimizing or switching meds including lithium, and considering ECT, TMS, or ketamine, alongside sleep and metabolic strategies while avoiding unproven stem cell clinics. There are several factors to consider; see below for complete details, cautions, and when to seek urgent help.

Bipolar mood swings reflect real changes in brain circuits, and meds can seem not to work because the biology is multi-pathway, the brain adapts over time, antidepressants alone can destabilize, adherence varies, and doses or combinations often need careful adjustment. There are several factors to consider; see below to understand more. Promising next steps include personalized treatment plans, long-acting injectables, carefully supervised ketamine or esketamine for select bipolar depression, neuromodulation such as ECT or TMS, evidence-based psychotherapy, and strict sleep and lifestyle routines, with urgent red flags and when to seek emergency care detailed below.

Yes, many U.S. clinical trials in 2024, including IBS studies, reimburse travel expenses such as mileage, public transit, parking, and sometimes lodging or airfare, but the exact amount and requirements depend on the sponsor and are spelled out in the informed consent. There are several factors to consider, including new IBS access rules that expand remote participation and require clearer, fair reimbursement; see below for typical payment ranges, what is taxable, timing and documentation, and the key questions to ask the study team before you enroll.

Constant bloating is often tied to small intestinal bacterial overgrowth or IBS; rifaximin is a locally acting antibiotic FDA approved for IBS-D and used off label for SIBO to reduce gas, bloating, and pain, often given as 550 mg three times daily for 14 days, with combination therapy considered for methane predominant cases. Right next steps include breath testing when appropriate and a plan that also addresses motility, diet, constipation, and underlying conditions, with urgent care for red flags like weight loss, blood in stool, severe pain, or vomiting. There are several factors to consider; see the complete details below to decide if rifaximin is right for you and how to prevent relapse.

There are several reasons Crohn’s can flare despite medication, including the drug not being the right fit or dose, low blood levels or antibodies, smoldering inflammation, strictures that need procedures, infections that mimic a flare, poor absorption of oral meds, and stress-related gut sensitivity. There is a structured path forward that confirms inflammation with blood, stool, imaging, and scoping, uses therapeutic drug monitoring, switches or combines therapies across classes, considers surgery when appropriate, and optimizes diet, sleep, smoking cessation, and mental health; see below for key specifics and urgent warning signs that could change your next steps.

When standard Crohn’s meds stop working, S1P modulators are a newer oral option that reduce gut inflammation by keeping certain immune cells in lymph nodes, offering a different pathway to remission even after biologic failure. There are several factors to consider, including who is a good candidate and how doctors monitor for risks like infections, heart rate changes at start, and liver effects. See the complete answer below for key benefits, safety checks, and questions to ask your doctor that could change your next steps.

There are several factors to consider: Crohn’s flares can persist due to primary non-response, loss of response from antibodies or low drug levels, difficult-to-penetrate inflammation, or fibrosis that may need surgery rather than meds. See below for Phase 3 breakthroughs that may change your options, including IL-23 inhibitors, oral JAK inhibitors, S1P modulators, refined anti-integrins, and precision strategies that are raising remission rates, plus key actions like drug-level monitoring and when to seek urgent care that could influence your next steps.

Most bipolar disability benefit denials happen due to missing medical and functional evidence, not because you do not qualify, with common pitfalls like inconsistent treatment, vague notes, limited proof of work limitations, and unexplained gaps that make it appear symptoms are controlled. New medical steps to qualify include consistent psychiatric care that documents episodes and side effects, a detailed RFC from your clinician, tracking mood and attendance, submitting hospitalization or crisis records, documenting co occurring conditions, and appealing on time. There are several factors to consider. See below for the complete checklist, SSA approval targets, and mistakes to avoid that could change your next treatment and appeal strategy.

There are several factors to consider: depression is biologically diverse, about one-third of people do not respond to a first antidepressant, and medical research volunteers are driving new science by enabling trials of rapid-acting medicines like ketamine-based options, brain stimulation such as TMS, and personalized tools that match treatments to biology. If your meds are not working, do not stop suddenly and speak with your clinician about dose changes, combinations, or clinical trials; for safety details, practical next steps, and a symptom check that could guide your plan, see below.

If Entyvio is losing effectiveness, current guidance supports transitioning to an oral JAK inhibitor such as upadacitinib or tofacitinib, using a protocol that confirms active inflammation, screens for risks and needed vaccines, uses minimal or no washout, starts induction dosing, and monitors closely for 8 to 12 weeks. There are several factors to consider, including rapid benefits and steroid-sparing potential balanced against infection, shingles, lipid changes, clots, and cardiovascular risks in higher‑risk patients. See below for step-by-step timing, testing checklists, who should avoid JAK inhibitors, and urgent warning signs that could change your next steps.

Feeling physically drained yet mentally wired can signal a bipolar mixed state, where depressive and manic or hypomanic symptoms happen together and increase the risk of impulsive behavior and suicidal thoughts. There are several factors to consider. See below to understand more, including how to track symptoms, use a screening tool, and talk with a clinician about mood stabilizers, atypical antipsychotics, therapy, sleep and substance habits, and when to seek urgent help.

UC J-pouch alternatives are increasingly common, from advanced biologic and small-molecule medicines to treatment optimization with second opinions, access to clinical trials, and the option of a permanent ileostomy, with lifestyle changes used as supportive care. There are several factors to consider, since severe or complicated disease may still require surgery; see below for the key risks and benefits, red flags that need urgent care, and the specific questions and next steps to discuss with your gastroenterologist.

Humira can stop working due to primary non-response or secondary loss of response from anti-drug antibodies, low drug levels, a shift to non-TNF inflammation, or symptoms not driven by active inflammation. The medical next steps are to confirm active disease and drug levels with CRP, fecal calprotectin, therapeutic drug monitoring, and sometimes colonoscopy, then either optimize Humira or add an immunomodulator, switch to another anti-TNF, or move to a different class such as vedolizumab, ustekinumab, IL-23 inhibitors, or JAK inhibitors, with surgery considered in select cases. There are several factors to consider. See below to understand more.

After Remicade and Humira stop working for ulcerative colitis or Crohn’s, there are still medically approved paths to remission. Options include gut-selective integrin blockade like vedolizumab, IL-23 or IL-12/23 inhibitors like risankizumab, mirikizumab and ustekinumab, oral JAK inhibitors like upadacitinib and tofacitinib, S1P modulators like ozanimod, plus combination therapy or clinical trials. There are several factors to consider, such as confirming true failure with drug levels and inflammation testing, using a treat-to-target plan, and knowing when urgent care or surgery is appropriate, so see the complete details below to guide your next steps.

After unsuccessful SSRI or SNRI trials, there are several factors to consider; the details below can affect which next steps are right for you. The evidence-based roadmap usually starts with a careful reassessment for misdiagnosis, adherence, and medical contributors, then moves to either switching to a different class (bupropion, mirtazapine, TCAs, MAOIs) or augmenting with agents like aripiprazole, quetiapine, lithium, T3, or bupropion, alongside psychotherapy. If needed, newer options such as esketamine or ketamine, TMS, or ECT are considered, and urgent care is advised for suicidal thoughts, psychosis, or inability to function; see below for how to choose among these.

Anti-TNF failure in Crohn’s is common and often due to antibodies, low drug levels, or non-TNF inflammatory pathways, so first confirm active inflammation and check trough levels and antibodies before switching. Trial-backed next steps include vedolizumab, ustekinumab, risankizumab, and upadacitinib, with clinical trials available if standard options are not enough. There are several factors to consider, including when strictures may need surgery, which safety checks to do, and urgent red flags. For the complete, step-by-step guidance to choose your best next move with your gastroenterologist, see below.

Failing second-line IBD therapy often has fixable causes, including low drug levels or antibodies, more aggressive or stricturing disease, non-inflammatory mimics like IBS or bile acid diarrhea, and modifiable factors such as missed doses, NSAIDs, infections, or smoking. Next steps typically include confirming true inflammation, therapeutic drug monitoring, dose optimization or combination therapy, switching within or across drug classes, considering trials, and surgical evaluation when needed; there are several factors to consider, and important red flags and decision points are detailed below.

IBD urgency at work is real, driven by active inflammation, a hypersensitive bowel, and stress; evidence-based fixes include optimizing medical therapy (often with rectal treatments), setting predictable morning and eating routines, using antidiarrheals only with doctor guidance, practicing brief calming techniques, and arranging reasonable workplace accommodations. There are several factors to consider, including red flags like bleeding, fever, severe pain, or rapid worsening that need prompt medical care. See the complete guidance below for key details that could shape your next steps and help you feel more in control at your desk.

Most bipolar crisis plans fail because they are vague, start too late, rely only on your insight, skip doctor-approved medication protocols, and are not reviewed; a stronger plan uses specific early warning signs, stepwise actions, pre-approved med changes, strict sleep protection, financial safeguards, and a named support team. New medical steps now emphasize data-based mood and sleep tracking, rapid access appointments, medication adherence support, and screening for coexisting conditions, plus clear triggers for urgent care; there are several factors to consider, and key details that could change your next steps are outlined below.

A high fecal calprotectin after treatment usually means intestinal inflammation is still present, even if symptoms improved; causes include slow mucosal healing, underdosed or ineffective meds, a developing flare, infection, NSAID use, hidden small‑bowel disease, or lab variation. Next steps often include repeating the test in 4 to 8 weeks, reviewing symptoms, ruling out infection, and discussing medication adjustments or imaging or colonoscopy with your clinician. There are several factors to consider that can change urgency and treatment choices; see below for key thresholds, red flags that need prompt care, and how to navigate a treat to target plan.

When a perianal fistula from Crohn’s keeps draining or recurring despite antibiotics, biologics, setons, or surgery, clinical trials can offer access to newer options such as next generation biologics, stem cell therapies, and targeted injections, with specialist oversight and structured safety monitoring. There are several factors to consider. See below for key details on eligibility, risks, visit schedules, what happens to your current meds, urgent red flags, and the exact questions to ask your IBD team to choose the right next step.

Many antidepressants can lead to weight gain by increasing appetite, slowing metabolism, or causing fatigue, but newer depression drugs that don't cause weight gain, such as bupropion, vortioxetine, vilazodone, and esketamine, may better protect metabolic health. Do not stop medication on your own; track changes and speak with your doctor about switching, dose adjustments, and metabolic labs. There are several factors to consider, including other medical causes and practical offset strategies; see below for details that could affect your next steps.

High calprotectin while you feel okay on meds often means silent gut inflammation that still raises your risk of relapse, bowel damage, hospitalization, and increased colorectal cancer risk in long-standing ulcerative colitis. Next steps usually include repeating calprotectin, checking biologic drug levels and antibodies, ruling out infection, and considering colonoscopy or medication optimization; there are several factors to consider that can change your plan, so see the complete guidance below.

Depression is a multisystem condition that can leave the brain feeling stuck due to changes in neurotransmitters, stress hormones, mood circuits, inflammation, sleep, and reduced neuroplasticity. The strongest results come from integrative care that pairs medical treatments like medication, evidence based therapy, and options such as TMS, ketamine, or ECT with holistic foundations like sleep repair, movement, nutrition, gut health, and trauma work, with lifestyle plus therapy often enough for mild cases and medication essential for severe. There are several factors to consider. See below to understand more, including when to seek urgent help, why treatment may stall, which labs to check, and the newest protocols like personalized psychiatry, anti inflammatory and microbiome strategies, digital CBT, and a practical stepwise plan to guide your next steps with your clinician.